These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22307680)

  • 1. The amyloid-β isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer's disease.
    Portelius E; Fortea J; Molinuevo JL; Gustavsson MK; Andreasson U; Sanchez-Valle R
    Mol Med Rep; 2012 Apr; 5(4):1111-5. PubMed ID: 22307680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.
    Portelius E; Andreasson U; Ringman JM; Buerger K; Daborg J; Buchhave P; Hansson O; Harmsen A; Gustavsson MK; Hanse E; Galasko D; Hampel H; Blennow K; Zetterberg H
    Mol Neurodegener; 2010 Jan; 5():2. PubMed ID: 20145736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease.
    Portelius E; Zhang B; Gustavsson MK; Brinkmalm G; Westman-Brinkmalm A; Zetterberg H; Lee VM; Trojanowski JQ; Blennow K
    Neurodegener Dis; 2009; 6(5-6):258-62. PubMed ID: 19955704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.
    Wiltfang J; Esselmann H; Cupers P; Neumann M; Kretzschmar H; Beyermann M; Schleuder D; Jahn H; Rüther E; Kornhuber J; Annaert W; De Strooper B; Saftig P
    J Biol Chem; 2001 Nov; 276(46):42645-57. PubMed ID: 11526104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity.
    Schilling S; Pradhan A; Heesch A; Helbig A; Blennow K; Koch C; Bertgen L; Koo EH; Brinkmalm G; Zetterberg H; Kins S; Eggert S
    Acta Neuropathol Commun; 2023 Jun; 11(1):87. PubMed ID: 37259128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock-in rats with homozygous
    Tambini MD; D'Adamio L
    J Biol Chem; 2020 May; 295(21):7442-7451. PubMed ID: 32265300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease.
    Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B
    Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-secretase binding sites in aged and Alzheimer's disease human cerebrum: the choroid plexus as a putative origin of CSF Aβ.
    Liu F; Xue ZQ; Deng SH; Kun X; Luo XG; Patrylo PR; Rose GM; Cai H; Struble RG; Cai Y; Yan XX
    Eur J Neurosci; 2013 May; 37(10):1714-25. PubMed ID: 23432732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
    Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
    Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
    Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
    J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques.
    Miravalle L; Calero M; Takao M; Roher AE; Ghetti B; Vidal R
    Biochemistry; 2005 Aug; 44(32):10810-21. PubMed ID: 16086583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta.
    Arber C; Toombs J; Lovejoy C; Ryan NS; Paterson RW; Willumsen N; Gkanatsiou E; Portelius E; Blennow K; Heslegrave A; Schott JM; Hardy J; Lashley T; Fox NC; Zetterberg H; Wray S
    Mol Psychiatry; 2020 Nov; 25(11):2919-2931. PubMed ID: 30980041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aβ43 levels determine the onset of pathological amyloid deposition.
    Tambini MD; Yin T; Yesiltepe M; Breuillaud L; Zehntner SP; d'Abramo C; Giliberto L; D'Adamio L
    J Biol Chem; 2023 Jul; 299(7):104868. PubMed ID: 37257821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γ-Secretase processing and effects of γ-secretase inhibitors and modulators on long Aβ peptides in cells.
    Ran Y; Cruz PE; Ladd TB; Fauq AH; Jung JI; Matthews J; Felsenstein KM; Golde TE
    J Biol Chem; 2014 Feb; 289(6):3276-87. PubMed ID: 24352661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient.
    Portelius E; Gustavsson MK; Zetterberg H; Andreasson U; Blennow K
    Neurodegener Dis; 2012; 10(1-4):138-40. PubMed ID: 22302034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ profiles generated by Alzheimer's disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset.
    Petit D; Fernández SG; Zoltowska KM; Enzlein T; Ryan NS; O'Connor A; Szaruga M; Hill E; Vandenberghe R; Fox NC; Chávez-Gutiérrez L
    Mol Psychiatry; 2022 Jun; 27(6):2821-2832. PubMed ID: 35365805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
    Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
    Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β
    Perrone F; Bjerke M; Hens E; Sieben A; Timmers M; De Roeck A; Vandenberghe R; Sleegers K; Martin JJ; De Deyn PP; Engelborghs S; van der Zee J; Van Broeckhoven C; Cacace R;
    Alzheimers Res Ther; 2020 Sep; 12(1):108. PubMed ID: 32917274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
    Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.